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The physical properties of asymmetric Janus particles are highly promising for future biomedical ap-
plications. However, only a few data is available on their biological impact on human cells. We inves-
tigated the biological impact of different Au@Fe3O4 Janus particle formulations in vitro to analyse speciﬁc
uptake modalities and their potential cytotoxic effects on human cells of the blood regarding intravenous
injection. We demonstrate that Au@Fe3O4 Janus particles exhibit a similar or even better biocompatibility
compared to the well-studied spherical iron oxide nanoparticles. The impact of Janus particles on cells
depends mainly on three factors. (1) Surface functionalization: NH2-functionalization of the Au or iron
oxide domain induces a pronounced reduction of cell viability in contrast to non-functionalized variants
which is caused by the damage of intracellular membranes. (2) The nature of the metal oxide component,
greatly affects cell viability, as shown by a comparison with Au@MnO Janus particles. (3) The overall
surface charge and the size of nanoparticles have a higher impact on internalization and cellular
metabolism than the Janus character per se. Interestingly, Janus particle associated DNA damage is in-
dependent of the effects on the cellular ATP level. However, not only the structure and functionalization
of the Janus particle surface determines the particle’s adhesion and intracellular fate, but also the
constitution of the cell surface as shown by different modiﬁcation experiments. The multifactorial in vitro
approach presented in this study demonstrated the high capability of the Janus particles. Especially
Au@Fe3O4 Janus particles bear great potential for applications in vivo.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Nanomaterials have gained increasing interest due to their ap-
plications in various ﬁelds of biology and medicine. With respect to
their unique physical and chemical properties, metallic nano-
particles in particular play an important role in imaging and ther-
apeutic applications [1]. Iron and manganese oxide nanoparticles
have been proven to generate powerful T2 or T1 contrast in MRI in
preclinical studies [2,3]. Other applications include hyperthermia
and drug delivery [4,5]. Furthermore, gold nanoparticles have
emerged as promising candidates for X-ray based imaging or; fax: þ49 3641 9325922.
(L. Landgraf), ingrid.hilger@
Ltd. This is an open access article uplasmon resonance imaging purposes [6,7]. The compatibility of
these spherical nanoparticle formulations to human cells has been
veriﬁed in extensive cytotoxicity, genotoxicity, and uptake studies
[8e12]. In the past decades, two-faced (Janus) particles with an
asymmetric structure have attracted tremendous attention because
they unite the beneﬁts of the described spherical nanoparticles.
From the biomedical point of view, Xu et al. described Au-Fe3O4
particles as dual functional probes inside of epithelial cells A431.
They showed excellent T2 relaxivities and harmlessness to cells
in vitro [13]. Kirui and co-workers also demonstrated their feasi-
bility to induce magnetic hysteresis loops and as well as their
capability to act as potent photothermal absorbers against cancer
cells [14]. Janus particles were also used on one site for the delivery
of platinum and on the other one for targeting the Her2/neu re-
ceptor protein in breast cancer cells[15] Furthermore, FePt-Au
served as good target-afﬁne MRI contrast agent after conjugation
with HmenB1 antibodies which recognize prostate-speciﬁcnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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for the manipulation of macrophages by an external magnetic ﬁeld
[17] and Ag@maghemite nanoparticles were shown to be suitable
cellular biomarkers [18].
The aforementioned optical, magnetic and drug delivery char-
acteristics make Janus particles very interesting candidates for
biomedical applications, but detailed data on their cytotoxicity on
human cells are missing. So far, experiments assessing the viability
of cells after only short exposure (24 and 48 h) to Au@Fe3O4 par-
ticles were done using MTT/ WST1 measurements [13,14]. Never-
theless, it is known that metal nanoparticles can inﬂuence these
assay systems [9,19].
In this study, we investigated the impact of different Au@Fe3O4
formulations on endothelial cells and monocytes, as the blood
circle would be the main route of nanoparticle distribution in the
body. Furthermore, we compared the Au@Fe3O4 to spherical iron
oxide and Au@MnO particles. The main features of our study were
particle stability in different solvents as well as uptake behaviour
and cellular metabolism. In order to assess the beneﬁts of inorganic
Janus particles over classical nanoparticles the following factors
were considered. (1) Since the uptake of spherical nanoparticles is
affected by surface NH2-functions [9], we examined whether a
comparable effect is detectable for asymmetric nanoparticles as
well and (2) whether NH2-functionalization has an impact on cell
metabolism and their directed uptake into cells. (3) To gain a
further insight into the effects on cellular metabolism, we corre-
lated intracellular uptake with cell vitality, cellular ATP levels, and
DNA integrity. (4) We compared the effects of Janus-speciﬁc
structural features on different cell lines to spherical particle vari-
ants and also (5) the impact of the metal oxide component by
comparing Fe3O4 and MnO. (6) Finally, we elucidated the role of
distinct components of the cell membrane on the adhesion and
internalization behaviour of Janus nanoparticles. We especially
addressed the question if disease-related modiﬁcations of the cell
membrane of endothelial cells [20], would affect the adhesion and
internalization of Janus particles. These results are important to
evaluate suitability of Janus particles for biomedical applications.Fig. 1. Schematic illustration of the gold at metal oxide Janus particles coated with thiole g
without amino functionalization (a) or with site-speciﬁc NH2-functionalization at the metal o
spherical control Fe3O4 (e). Fluorescence of the FITC labelled metal oxide core of the nanop2. Experimental section
2.1. Synthesis and physico-chemical characterization of the Janus
particles
Gold nanoparticles were synthesized using a modiﬁed proce-
dure reported by Peng et al. [21]. The Au@Fe3O4 and Au@MnO-
heterodimers were prepared using a seed-mediated chemical
protocol [22,23]. Using standard Schlenk techniques, 15 mg of Au
nanoparticles, 6 mmol (2 mL) of oleylamine, 6 mmol (2 mL) oleic
acid, and 20 mL of 1-octadecene were heated up to 120 C in an
argon atmosphere followed by the injection of 2 mmol (0.27 mL) of
iron pentacarbonyl. The mixture was heated with a heating rate of
3.3 C/min to reﬂux, the heating was maintained for 1 h. After
cooling down to room temperature, the particles were collected by
adding isopropanol (ﬁve times the volume of the mixture), fol-
lowed by centrifugation (9344g, 10 min) and re-dispersion in
hexane. This process was repeated two times in total. Mono-
disperse isotropic magnetite and manganese oxide nanoparticles
were synthesized by thermal decomposition of the iron(III)oleate
or manganese(II)oleate in 1-octadecene described previously
[24,25]. Subsequently, the metal oxide components were coated
with a silica-PEG shell with the incorporation of the ﬂuorescence
dye FITC [26]. The silica-shell was further functionalized with
amine-groups using 3-aminotriethoxysilane within a second
condensation reaction. The gold components were functionalized
using either 1-octadecanethiol for amphiphilic particles or cyste-
amine for amine functionalization of the gold domain.
A schematic presentation of the Janus particles used in this
study is provided in Fig. 1(a, b and c). The determination of the
core sizes of 150 nanoparticles was performed by transmission
electron microscopy (TEM) (Philips EM 420, LaB6 cathode, 120
kV acceleration voltage). The measurements of the hydrody-
namic diameter, which reﬂects the colloidal stability and zeta-
potential of the nanoparticle formulations were carried out us-
ing dynamic light scattering (DLS) (Zetasizer Nano-ZS, Malvern
Instruments, Herrenberg, Germany). Prior to the measurements,roups at the gold domain and with a silica-FITC-PEG shell at the metal oxide domain,
xide (b) or at the gold core (c). TEM images of the Au@Fe3O4 Janus particles (d) and the
articles (f). TEM scale bars: 20 nm.
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Bandlein, Berlin, Germany) in deionized water. Thereafter, the
nanoparticle formulations were incubated for 3 days in complete
culture medium (10% foetal bovine serum (FBS)), medium
without FBS or in buffered saline (HBSS) at 37 C in an incubator
(5 % CO2 and 95% humidiﬁed environment) (Table 1). Afterwards,
the culture medium was removed by centrifugation for 30 s at
25.000g according to Cho [27]. The nanoparticle pellet was re-
suspended in deionized water. The average hydrodynamic
diameter was determined from an average of 5 measurements.
Zeta-potential measurements were performed in triplicate, each
with ten runs at 25 C.
2.2. Cell culture
The immortalized human micro vascular endothelial cells
(HMEC-1; Centers for Disease Control and Prevention, USA) were
cultured in Gibco MCDB 131 medium supplemented with 10% (v/
v) FBS, 1% (v/v) GlutaMAX I (100; Life Technologies GmbH,
Germany), 1 mg/mL hydrocholesterol (SigmaeAldrich Chemie
GmbH, Germany), 10 ng/mL epidermal growth factor (Life Tech-
nologies GmbH, Germany). The primary human umbilical vein
endothelial cell line (HUVEC) and the mouse macrophages
(J774A.1) were purchased from Cell line service (CLS, Germany).
HUVECs were cultured in Endothelial Cell Growth medium after
adding the Supplement Mix (Promocell, Germany). J774A.1 were
grown in Gibco DMEM/Ham’s F12 medium supplemented with
10% (v/v) FBS (Life Technologies GmbH, Germany). Fresh mono-
nuclear cells were isolated from whole blood via Ficoll-Hypaque
(LSM 1077, PAA Laboratories GmbH, Austria) differential centrifu-
gation and cultured in Gibco RPMI medium supplemented with
10% of inactivated FBS and Glutamin (Life Technologies GmbH,
Germany). All used cell lines were cultured at 37 C in a 5% CO2
humidiﬁed environment.
For experimentation, all cells were plated onto a plastic matrix
at a density of 1.2104 cells/cm2 (endothelial cells) or
1.8 104 cells/cm2 (monocytes), then allowed to grow for 24 h
before any nanoparticle exposure. The cells were mycoplasma-free
as routinely determined via PCR.
2.3. Evaluation of the nanoparticle effects on cell metabolism (ATP)
and generation of ROS
To determine effects of the nanoparticles on cell metabolism,
the cellular ATP levels were used as marker. Following 3, 24, 48, or
72 h of incubation at nanoparticle concentrations ranging from 0.1
to 100 mg/mL Fe(II)/(III) with subsequent removal by several
washing steps, the cellular ATP levels were assessed using the
ATPLite assay (PerkinElmer, Rodgau, Germany) according to the
manufacturer’s instructions. The luminescent signals emerging
from the transformation of D-luciferin to oxyluciferin were
measured using the LUMIstar Galaxy (BMG LABATECH GmbH,
Ortenberg, Germany) system. The determined ATP levels after
nanoparticle exposure were normalized to non-treated control
cells.
The production of reactive oxygen species during nanoparticle
incubation was measured by the OxiSelect Intracellular ROS
Assay Kit (BioCat GmbH, Germany) according to the manufacturer’s
instructions. The ﬂuorescence signals generated by the oxidation of
the non-ﬂuorescent 20,70-Dichlorodihydroﬂuorescin (DCFH) to
highly ﬂuorescent 20, 70-dichlorodihydroﬂuorescein (DCF) by ROS
were measured with a microplate reader (inﬁnite M1000 PRO,
Tecan Trading AG, Switzerland). The determined ﬂuorescence in-
tensities were normalized to control values and in a second step to
the number of viable cells.2.4. Determination of viable cell numbers after Janus particle
exposure
To further investigate the cell vitality after Janus particle expo-
sure, we determined the number of viable cells. HMEC-1 were
treated with 1, 50, or 100 mg/mL of Fe (II)/(III) for 24 h at 37 C.
Untreated cells served as a control for the viability of non-treated
cells. After washing, cell numbers were determined via bright-
ﬁeld microscopy using the EVOS (PEQLAB, Erlangen, Germany)
system. Hereto, we counted all cells in one ﬁeld-of-view of
665 mm2. The position of the ﬁeld-of-view always shared its cen-
tral point with the central point of the well. Cell counting was
performed thrice. Corresponding means were deﬁned as viable cell
number per ﬁeld-of-view (665 mm2).
2.5. Determination of genotoxic effects of the Janus particle
formulations
The potential genotoxic impact of the Au@Fe3O4 Janus particles
was measured using the ‘Comet assay’, which was performed ac-
cording to a protocol described by Singh and Glei [28,29]. Brieﬂy,
endothelial cells were exposed to different Janus particle concen-
trations (1, 10, or 50 mg/mL) for 24 h at 37 C. After several washing
steps, cells were detached from the plastic matrix with trypsin and
then harvested by centrifugation for 5 min at 4 C and 2500g. The
cell pellets were suspended in 0.7% low melting agarose and
transferred to glass slides covered with 0.5% normal melting
agarose. Subsequently, all slides were placed into a lysis bath
(100 mM Na2EDTA, 1%Triton X-100, 2.5 mM NaCl, 10 mM Tris-Base,
NaOH, 1% Na-Lauroylsarcosin, 10% DMSO) over night. After
washing with electrophoresis buffer (1 mM Na2EDTA, 300 mM
NaOH), DNA unwinding was performed by incubation in the alka-
line buffer (1 mM Na2EDTA, 300 mM NaOH) for 20 min in the elec-
trophoresis chamber. Electrophoresis was performed at 25 V,
300 mA for 20 min. Subsequently, the samples were washed three
times with phosphate buffered saline (pH 7.3) and subsequently
stained with 30 mL SYBR Green. The ﬂuorescence intensities of
head and tail were measured by considering the nuclei of a tripli-
cate of 20 cells in different ﬁelds of view via the comet assay
software (Comet Assay IV, Perceptive Instruments Ltd, Bury St
Edmunds, UK). DNA damage was calculated as the percentage of
cell nuclei showing a comet tail.
Additionally, cells were also stained for phosphorylated histones
as further indicator of DNA damages. In this context, HMEC-1 was
grown in T-25 culture ﬂasks. After the treatment with nano-
particles, cells were ﬁxed, permeabilised, blocked and labelled with
the Anti-Histone H2A.X antibody (abcam, UK) and ﬂuorescence-
labelled by the Goat Anti-Rabbit IgG H&L (cy5)IgG (abcam, UK)
secondary antibody according to the manufacturer’s protocol.
Fluorescence intensity, which correlates with phosphorylated
serin139, was measured with a FACSCalibur (BD Bioscience, USA)
at 640/670 nm.
2.6. Determination of the uptake behaviour of different
nanoparticle formulations via microscopy
To analyse the uptake of nanoparticles, HMEC-1 was incubated
with the nanoparticle formulations at non-cytotoxic concentra-
tions of 1 or 5 mg/mL Mn (II) or Fe (II)/ (III), respectively. After
washing with HBSS to remove non-internalized particles, cells
were ﬁxed with 4% formaldehyde for 10 min at 4 C. The cells were
stained with Prussian blue as described earlier [30] for detection of
iron via bright-ﬁeld microscopy (EVOS, PEQLAB Biotechnologie
GMBH, Germany). Likewise, the detection of the iron oxide and
manganese oxide component was done via ﬂuorescence
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GmbH, Jena, Germany), based on exciting the FITC that was
coupled to the metal oxide domain at 488 nm. To assess the
morphological features of the cells after nanoparticle exposure,
nuclei were stained with Hoechst 33258 (Applichem, Darmstadt,
Germany) and the glycocalyx with lectin WGA-AlexaFluor633
(Invitrogen GmbH, Darmstadt, Germany). TEM was also per-
formed to obtain information about the intracellular localization of
the Au@Fe3O4 Janus particles. In this regard, cells were cultured in
24-Well plates as described above until they reached 90% con-
ﬂuency. Janus particles were incubated for 24 h and cells were
ﬁxed with 2% (v/v) glutaraldehyde solution (EM grade in 0.1 M
cacodylate buffer, pH 7.4) containing 5% sucrose at 20 C for
30 min. Next, cells were washed in cacodylate buffer (0.1 M, pH 7.4,
6.8% sucrose) and post-ﬁxed with a freshly prepared mixture of 1
volume 2% OsO4 (dissolved in distilled water) and 1 volume of 3%
K4[Fe(CN)6] in 0.2 M cacodylate buffer (pH 7.4) at 4 C for 2 h. Then,
cells were rinsed with 0.1 M cacodylate buffer until the solution
remained clear, dehydrated in graded series of ethanol and
embedded in Epon 812 via hydroxypropylmethacrylate as inter-
medium. Epon sheets containing cell layers were ﬁnally cured in an
oven at 60 C for 6 days. Ultrathin sections were made with low
angle diamond knives (Diatome, Biel, Switzerland) at a Leica
Ultracut S ultramicrotome and stained with freshly prepared ura-
nyl acetate and lead citrate. The sections were examined using a
transmission electron microscope EM 902A (Zeiss, Germany) at an
accelerating voltage 80 kV.
2.7. Semi-quantitative analysis of the nanoparticle uptake
The amount of nanoparticles internalized in HMEC-1 was
calculated by a microscopic semi-quantitative analysis of cells,
which were previously treated with nanoparticles as described
above. These analyses were done by randomly choosing 3 different
ﬁelds of view of 74 mm2 surface area and by counting all visible
cells in these areas. The method was controlled by two experi-
menters using blinded samples. Afterwards, analysis of the pres-
ence of cells loaded with nanoparticles was done via ﬂuorescence
(FITC) or bright-ﬁeld microscopy (Prussian blue). The uptake rate
was normalized as the percentage of cells with nanoparticles.
2.8. Determination of the impact of the endothelial cell surface on
uptake of Janus particle
To assess the role of the endothelial cell surface on nanoparticle
uptake, three different methodologies were used. The ﬁrst method
used the inversion of endothelial cells to get access to the basal cell
surface faced to the Janus particles according to Muller and Gim-
brone [31]. To invert cells, HMEC-1 was ﬁrst seeded with a density
of 2.4104/cm2 cells in petri dishes and incubated for 24 h at 37 C.
After washing three times with buffer, sterile cover slips were
thoroughly placed over the apical cell surface. The cover slips were
transferred to a new petri dish containing fresh culture medium
with the bottom side up. Then the cells were incubated for addi-
tional 3 h to allow for adhesion to the cover slips. Afterwards, Janus
particles (1 mg/mL Fe (II)/(III) or Mn (II)) in culture medium were
added and incubated for 3 h. After removing unbound nano-
particles by washing, the cells were ﬁxed and stained for micro-
scopy as described above.
In the second approach, the cell membrane proteins were
modiﬁed by cleaving of peptide bonds between the amino acids
lysine and arginine by trypsination. Brieﬂy, HMEC-1 was seeded at
a density of 1.2104/cm2. 24 h later cells were washed three times
with 200 mL/well HBSS, and incubated with 100 mL/well trypsin
(GIBCO, Life Technologies GmbH, Germany) for 3 min at 37 C.The third method aimed to elucidate the potential role of lectins
on the uptake of Janus particles by a pre-incubation step of Janus
particles with WGA. In this context, cells were ﬁrst incubated with
5 mg/mL WGA (WGA-AlexaFluor633, Invitrogen GmbH, Darmstadt,
Germany) for 10 min and subsequently co-incubated with Janus
particles (Table 1) (1 mg/mL of Fe (II)/ (III) or Mn (II)) for 3 h. Cells
without any pre-treatment with trypsin were used as controls for
adhesion of Janus particles to a non-modulated cell surface. All cell
samples were ﬁnally washed with buffer, ﬁxed, and the cell nuclei
were stained with Hoechst 33258 (Applichem, Darmstadt, Ger-
many) for ﬂuorescence microscopy. Alternatively, iron oxide was
stained with Prussian blue for bright-ﬁeld microscopy according to
Song [30].
2.9. Statistical analysis
All data measured in 96-well plate format are given as mean -
 standard deviation of one (3e6 parallels) or three (12 parallels)
independent experiments. The data were analysed using the Wil-
coxoneManneWhitney U-test (IBM SPSS Statistics, IBM Deutsch-
land GmbH, Ehningen, Germany). Statistical signiﬁcance was
calculated by comparing untreated (control) with nanoparticle
treated samples. P values <0.05 are considered as signiﬁcant.
3. Results
3.1. Nanoparticle characterization
The Au@Fe3O4 Janus particles used in this study differed in the
position of their NH2-functionalization. The schematic illustration
and the transmission electron microscopy (TEM) images in Fig. 1
represent the composition of the Janus particles. To elucidate the
impact of Janus-speciﬁc structural features on human cells spher-
ical iron oxide nanoparticles and Au@MnO Janus particles were
used for comparison. TEM revealed particle core sizes of 3.5 nm for
the gold domain and about 16 nm of the iron oxide domain (Fig. 1
and Table 1). In particular, the bare Au@Fe3O4 and the Au@Fe3O4-
NH2 particles showed colloidal stability in water measured by DLS
(Table 1). Interestingly, the Au-NH2@Fe3O4 variant showed large
agglomerates up to 1 mm in size (Table 1, hydrodynamic diameter
dh). Furthermore, the three different Au@Fe3O4 Janus particle var-
iants were incubated in different buffers (with or without 10%
foetal bovine serum (FBS) Table 1 and Supplementary Table S1) to
assess both the effects of the asymmetric character and the alter-
nating position of NH2-groups on the nanoparticle stability and the
formation of a protein corona. Following incubation in culture
medium supplemented with 10% FBS, the hydrodynamic diameters
of almost all the particles increased (byw50 nm) which reﬂects the
formation of a protein corona and some clustering of the particles.
Interestingly, incubation of the nanoparticles with serum-free
culture medium showed much higher hydrodynamic diameters
(w600 nm) than that with 10% FBS (compare Table 1 and
Supplementary Table S1), which indicates agglomeration.
Furthermore, the Zeta-potentials revealed that Janus particle for-
mulations are negatively or positively charged in water depending
on the presence or absence of surface NH2-groups. After incubation
with serum proteins, the Zeta-potentials changed to the opposite
charge which conﬁrms the formation of a protein corona on the
particle surface (Table 1). Interestingly, the change in the Zeta-
potential was only observed for relatively stable nanoparticles.
3.2. Effects of amino functionalization of Janus particles
At iron concentrations up to 20 mg/mL Fe(II)/(III) the NH2-
functionalized Janus particles revealed a higher impact on the
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groups. Interestingly, at concentrations higher than 50 mg/mL
Fe(II)/(III) the Au-NH2@Fe3O4 particles had a signiﬁcantly
(p< 0.05) stronger effect on cellular metabolism than Au@Fe3O4-
NH2 and non-functionalized particles. This cytotoxic impact of Au-
NH2@Fe3O4 particles on the cells was distinct after 24 and 48 h
incubation (Supplementary Fig. S1a and b) and especially pro-
nounced after 72 h incubation (Fig. 2a). For the spherical Fe3O4
(Fig. 2a (ii)) and the MnO (Supplementary Fig. S1) nanoparticles
we also observed a higher impact on the cellular ATP level when
functionalized with NH2-groups. In a further step, we studied the
uptake behaviour of Janus particles by endothelial cells (HMEC-1).
In order to detect possible site-speciﬁc effects of the NH2-func-
tionalization (Au vs. metal oxide domain) a non-cytotoxic con-
centration of 5 mg/mL Fe(II)/(III)) was used for microscopy. After
three days of incubation all the investigated Janus particles
revealed a predominantly perinuclear distribution (Fig. 2b). Non-
functionalized Au@Fe3O4 Janus particles accumulated to a
slightly higher extent than functionalized Janus particle variants,
irrespective of the localization of the NH2-groups (Fig. 2b and c).
TEM investigations revealed localisation of Au-@Fe3O4 Janus par-
ticles in endosomes, followed by ﬁnal deposition in secondary
lysosomes (Fig. 2d). The integrity of endosomal as well asFig. 2. Effect of surface functionalization on cellular ATP levels and nanoparticle uptake.
Relative cellular ATP levels were detected by ATPLite assay after 72 h. (i) HMEC-1 treated w
Fe3O4eNH2. Data were normalized to control values (no particle exposure), which were set
5 mg/mL Fe (II)/(III) for 72 h. The iron component of the nanoparticles was stained with Pruss
Janus particles (blue). Scale bars: 20 mm. (c) Semi-quantitative analysis of the nanoparticle u
mL Fe (II)/(III) of Au@Fe3O4 and Au@Fe3O4eNH2.lysosomal membranes seemed to be unaffected. In striking
contrast to that, endocytosis of Au-NH2@Fe3O4 variants resulted in
appearance of numerous signiﬁcantly larger endosomes scattered
over the entire cytoplasm (Fig. 2d). Moreover, numerous appear-
ances of primary lysosomes towards the endosomal membranes
were remarkable. Interestingly, uptake of Au-NH2@Fe3O4 particles
by HMEC-1 cells lead to frequent disruptions of membranes of
endosomes and secondary lysosomal membranes (Fig. 2d).
Disturbed membrane integrity of endosomes and secondary ly-
sosomes was indicated by distinct release of Au-NH2@Fe3O4 par-
ticles into the cytoplasm.
3.3. Effects on cell metabolism
To obtain a comprehensive picture of the impact of Janus par-
ticles on cells, the following readouts were analysed: (a) DNA
integrity, (b) cell vitality, and (c) cellular ATP levels. Interestingly,
damage to DNA was primarily observed for Au@Fe3O4 Janus parti-
cles without NH2-functionalization (Fig. 3a). A comet assay showed
an increase of DNA damage after incubation with the bare Janus
particles. This was indicated by increased tail intensities up to 20%
compared to untreated control and to cells incubatedwith the NH2-
functionalized Janus particles (Fig. 3a). Janus particles with aminoEndothelial cells were incubated with increasing concentrations of nanoparticles. (a)
ith Au@Fe3O4, Au@Fe3O4-NH2 and Au-NH2@Fe3O4. (ii) HMEC-1 treated with Fe3O4 and
as 100% ATP level. *p< 0.05. (b) Uptake of nanoparticles into cells after incubation with
ian blue for microscopy or visualized by ﬂuorescence microscopy of FITC. Localization of
ptake (for details see text). (d) TEM images of HMEC-1 after 24 h incubation with 5 mg/
Fig. 3. Comparative impact of Janus particles on DNA integrity, the number of viable cells and energy metabolism after nanoparticle exposure. HMEC-1 were incubated with 50 mg/
mL Fe (II)/(III) of the Au@Fe3O4 Janus particle formulations or without nanoparticles (native) for 24 h. (a) Box-plot diagrams indicate the DNA integrity shown as tail intensity (comet
assay, for details see text) compared to untreated native cells. (b) Number of cells per section measured during microscopy (for details see text). (c) Relative cellular ATP levels are
detected by ATPLite assay. Tail intensities of 20 cells were measured in triplicate by the comet assay software. ATP data were normalized to control values (no particle exposure,
native), which were set as 100%.
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number of viable cells (Fig. 3b and c). Especially, the Au-NH2@Fe3O4
led to a decreased value of cell numbers compared to untreated
cells (native).
3.4. Cytotoxic proﬁle of Janus particles
To determine the effect of structural features on cytotoxicity, we
compared asymmetric Janus particles with spherical Fe3O4 nano-
particles. Interestingly, the non-spherical Au@Fe3O4 Janus particles
induced no changes on ATP levels, whereas the spherical Fe3O4
nanoparticles induced an increase in cellular ATP levels after 24 h
of incubation (Fig. 4a). However, after 72 h of incubation
(Supplementary Fig. S1c) Janus particles induced a dose-dependent
steady decrease of the relative cellular ATP levels. The transient
proliferative effect of Fe3O4 nanoparticles is probably attributed to
the production of reactive oxygen species (ROS) (Fig. 4b). ROS
production was twice as high for the spherical nanoparticles as for
untreated cells. Moreover, the Au@Fe3O4 Janus particles reduced
the ROS level compared to non-treated control cells. Relatively low
genotoxic effects of both nanoparticle variants were substantiated
by the comet assay in Figure 4c and by the ﬂow cytometry analysis
of phosphorylated histones (Supplementary Fig. S2).
Janus and spherical nanoparticles showed distinct effects in
different cell types. The impact on primary endothelial cells(HUVECs) was similar for both nanoparticle formulations (Fig. 4d),
but the primary cells were more sensitive than the permanent cell
line, HMEC-1 at a concentration of 50 mg/mL Fe(II)/(III) (Fig. 4a). In
addition, the permanent macrophage cell line (J7741.A, Fig. 4e)
showed a dose-dependent reduction of cellular ATP levels after
exposure to spherical as well as Janus nanoparticles. This means
that the concentration of the iron oxide determines the sensitivity
of these cell lines to the particles. In mononuclear cells isolated
from fresh human blood, the spherical nanoparticles led to a
stronger decrease in cellular ATP levels than Janus particles. Both
variants showed a perinuclear localization and the uptake rates
around 60% spherical and Janus particle (Supplementary Fig. S3)
were comparable. It is therefore unlikely that a higher uptake of the
spherical Fe3O4 nanoparticles into HMEC-1 contributed to the
stronger effects described above.
3.5. Metal oxide component of Janus particles
Comparison of different metal oxides showed decreased cellular
ATP levels concentrations above 5 mg/mL Mn(II) (Fig. 5b). The up-
take of the Au@MnO vs. the Au@Fe3O4 Janus particles without NH2-
functionalization revealed no distinct differences (Fig. 5b, compare
(i) and (ii)). The intracellular distribution of all Janus particle for-
mulations used in this study showed a perinuclear localization.
According to data from semi-quantitative analysis, almost all cells
Fig. 4. Inﬂuence of the asymmetric nanoparticle structure on cellular ATP levels of different cell lines, cellular ROS level, and DNA damage after 24 h of incubation with increasing
concentrations of Au@Fe3O4 Janus and spherical Fe3O4 nanoparticles. (a) Cellular ATP level of permanent endothelial cells (HMEC-1). (b) Relative cellular ROS levels of HMEC-1 were
detected by OxiSelect ROS assay. (c) Box-plot diagrams indicate the DNA integrity shown as tail intensity (comet assay, for details see text) compared to untreated native cells.
Cellular ATP levels of (d) primary endothelial cells (HUVECs), (e) permanent macrophages (J774A.1) and (f) freshly isolated human mononuclear cells. ATP data was normalized to
control values (no particle exposure), which were set as 100% ATP level. The ROS values were normalized to viable cell number. *p< 0.05.
L. Landgraf et al. / Biomaterials 35 (2014) 6986e69976992internalized the Janus particle formulations (Fig. 5c left and right).
Thus, the enhanced effects of Au@MnO particles on the cellular
metabolism are not a consequence of a higher uptake, but rather
result from the different cytotoxic potential, as observed previously
for the spherical counterparts.
3.6. Impact of incubation time e cellular ATP and internalization of
Janus particles
We observed a time-dependent reduction of cellular ATP levels
after incubating endothelial cells with Janus particles. Fig. 6a((i)
and (ii)) shows that the relative cellular ATP level was not signiﬁ-
cantly affected after 3 h of incubation with Au-NH2@Fe3O4 and Au-
NH2@MnO particles (p> 0.05). However, it dropped signiﬁcantly
after 24 h (Fig. 6a). Moreover, a concentration dependency over
time was observed, which was very prominent for concentrations
>50 mg/mL Fe(II)/(III) and >1 mg/mL Mn (II). The concentration of
5 mg/mL Mn(II) seems to be the critical cytotoxic concentration. For
the Au-NH2@MnO particles, we observed an increase of the ATP
level up to 1 mg/mL after 72 h of incubation, which was caused by
hormesis. The extent of internalization of the ﬂuorescence labelled
Au-NH2@MnO Janus particles (ﬂuorescence in Fig. 1f) by HMEC-1
was demonstrated by confocal laser scanning microscopy
(Fig. 6b). After 3 h incubation, an incipient adhesion of the Janus
particles on the cell membranes could be detected by a z-stacking
analysis (green dots above the red cell membrane in Fig. 6c). After
24 and 48 h of incubation, FITC labelled Au-NH2@MnO nano-
particles were visible inside the cells (Fig. 6b, green). Interestingly,
after 24 h of exposure the Janus particles were fully internalized
into HMEC-1 detected by z-stacking (green dots located on thesame plane as the blue nucleus in Fig. 6c). These ﬁndings suggest
that uptake of the Janus particles occurred between 3 and 24 h of
treatment, which is in agreement with the encountered time-
dependent reduction of ATP levels (see above). Similar relation-
ships were also observed in control experiments with spherical
nanoparticles indicating that these are not merely Janus-speciﬁc
effects.
3.7. Constitution of endothelial cell surface and Janus particle
internalization
In order to assess the role of the cell surface of endothelial cells
on the uptake and internalization of Janus nanoparticles, we used
different methods to modify the cell surface prior to incubation
with nanoparticles. Interestingly, the utilization of inversion cul-
tures showed stronger adhesion of Au@Fe3O4 Janus particles to the
basal cell surface compared to the apical surface (Fig. 7a, blue),
irrespective of the position of amino groups. Furthermore, a
stronger ﬂuorescence intensity of Au-NH2@MnO nanoparticle was
observed at the basal cell surface compared to the apical one
(Fig. 7b, green). Microscopy data demonstrate only an attachment,
but no internalization of the Janus particles into cells after 3 h of
particle exposure (Fig. 7b, z-stack). Moreover, if the cell membrane
is modiﬁed by gentle trypsination, nanoparticle uptake is distinctly
reduced (no ﬂuorescence in Fig. 7c). This observation demonstrates
that lysine- and arginine-containing proteins are necessary for the
adhesion of Janus particles to the endothelial cell surface. Inter-
estingly, co-incubation of cells with the lectin WGA (wheat germ
agglutinin) led to an increased uptake of Au-NH2@MnO Janus
particles (Fig. 7d, green).
Fig. 5. Inﬂuence of different metal components of Janus nanoparticles on cellular ATP
levels and internalization. To measure the ATP levels, endothelial cells were incubated
for 24 h with increasing concentrations of Au@Fe3O4 and Au@MnO Janus particles. (a)
Relative cellular ATP content was detected by ATPLite assay. Data were normalized to
untreated cells set as 100%. *p< 0.05. (b) Microscopical analysis of nanoparticle up-
take: (i) HMEC-1 after treatment with Au@Fe3O4, (ii) Au@MnO, scale bars indicate (i)
50 mm or (ii) 20 mm. Red arrows: Prussian blue stained nanoparticles (blue). White
arrows: FITC labelled nanoparticles (green). Nuclei (blue). (c) Semi-quantitative anal-
ysis of the nanoparticle uptake after 24 h of incubation with 1 mg/mL of metal oxide
(for details see text). Internalized Au@Fe3O4 nanoparticles: blue bars and Au@MnO:
green bars.
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Our data presented in this study demonstrated a high capability
of the Janus particles to human blood cells. Especially the bare
Au@Fe3O4 Janus particles bear great potential for applications
in vivo as a result of their harmlessness and their great potential for
multimodal imaging and drug delivery. The nanoparticle clustering
in complete culture medium can be selectively inﬂuenced by the
introduction of amino groups. The self-assembly of Janus particles
into clusters and micelles due to the amphiphilic character has
been demonstrated before [32e34]. This amphiphilic feature of the
Janus nanoparticles is governed by the nature of their surface
functionalization [18,35]. Interestingly, clustering occurred in
buffers without serum proteins which indicates that the nano-
particles were partly stabilized by the protein corona in FBScontaining medium [36]. Based on this information and on the fact
that colloidal stable nanoparticles are essential for in vivo studies,
free NH2-functionalization at the gold domain should be saturated
with adequate bioactive agents (e.g. chemotherapeutic agents) in
further developments and applications in biomedicine. We assume
that a dipole with a positively and negatively charged surface is
generated by the NH2-functionalization of the gold domain, leading
to mutual attraction of Janus particles and hence to an increase of
the hydrodynamic diameter. In general, Janus nanoparticles with
NH2-groups showed a lower stability than comparable variants
without NH2-groups (Table 1). The adhesion of opposite charged
serum proteins, as detected by the changes of zeta-potential, was
only true for stable nanoparticles. This is similar to measurements
by Lundqvist [37]. Taken together, our data show that surface
charge and NH2-functionalization of a nanoparticle are crucial
factors controlling colloidal stability and the formation of a protein
corona which in turn decide the processing of the nanoparticles in
biological environments. These factors outweigh the role of the
asymmetric Janus character.
Amino functionalized Janus particles revealed a generally lower
biocompatibility than bare Janus particles. These ﬁndings are in
accordancewith recent reports of other groups where it was shown
that NH2-functionalization increases the cytotoxic impact of
spherical nanoparticles [38]. Substantially decreased cellular ATP
levels were attributed to clustering and thus sedimentation of this
variant. However, it is not clear to which extent the effects are
related to Janus particle speciﬁc clustering [27,39]. In general, the
impact of NH2-functionalization was dose dependent, and to a
lesser degree also site-speciﬁc. Uptake studies revealed an accu-
mulation of bare Janus particles after three days of incubation. This
can be attributed to a difference in surface charge, as indicated by
the z-potentials after incubation in culture medium and the asso-
ciated formation of a protein corona [37,40]. The fact that previous
data [9] on z-potentials of nanoparticles are mostly based on sus-
pensions in water makes direct data comparison difﬁcult. Our data
on the different effects of solvents (water and culture media) on z-
potentials of nanoparticles therefore address an important aspect
which is indispensable for research with nanoparticles. Analysis of
internalization by TEM explains the effects of amino functionalized
particles as measured via the ATP assay. It is conceivable that these
events are caused by the release of the acidic contents of endo-
somes and secondary lysosomes into the cytoplasm and may
explain the higher impact on the cell metabolism of NH2-func-
tionalized Janus particles. Taken together, our ﬁndings on cellular
ATP metabolism indicate that NH2-functionalized Janus particles
lead to stronger reduction in cellular ATP levels independent of the
level of uptake of these variants. Furthermore, no distinct uptake
into HMEC-1 as a consequence of site-directed functionalization
(NH2 function at the gold or metal oxide domain) was detected. The
ﬁnding implicate that the overall surface charge due to the func-
tionalization have a higher impact on internalization and cellular
metabolism than the Janus character per se.
Comparative evaluation of the NH2-functionalization showed an
impact of the bare (non- NH2-functionalized) particles on DNA
integrity without effects on cell metabolism and cell numbers. The
underlying reasons for the observed genotoxic effects of Au@Fe3O4
nanoparticles remains unclear. Although the particles localized
predominantly at the perinuclear regions and not directly within
the nuclei of cells, it is very likely that speciﬁc interactions take
place between the particles or particle components with DNA.
Similar effects have been observed for particles with APTMS
coating and hydrodynamic diameters of 10 nm and 100e500 nm
[9]. Since the cells remained viable, as determined by cell counting
and cellular ATP levels, the cellular DNA repair system should still
be intact. In contrast, NH2-functionalized particles did not induce
Fig. 6. Effect of incubation duration on cellular ATP level and internalization of Janus particles. (a) Cellular ATP level of endothelial cells after 3, 24, 48 and 72 h treatment with
different concentrations of (i) Au-NH2@Fe3O4 and (ii) Au-NH2@MnO Janus particles. Data were normalized to untreated control cells. *p< 0.05. (b) Confocal ﬂuorescence and bright-
ﬁeld (overlay) images of Au-NH2@MnO Janus particle internalization after 3, 24 and 48 h incubation with 1 mg/mL Mn(II). Scale bars: 20 mm. (c) Confocal image z-stacks showing the
position of Au-NH2@MnO Janus particles after 3 and 24 h of incubation. (d) Semi-quantitative analysis of the nanoparticle uptake (for details see text). Localization of Janus particles
(green). Nucleus (blue). Cell membrane (red).
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viable cells without any impairment of the cellular ATP levels. In
contrast, Au@Fe3O4-NH2 and Au-NH2@Fe3O4 formulations induced
cell death through mechanisms other than genotoxicity. This low
cytotoxicity and the ability to repair these slight DNA damage
support the high bicompatibility of Au@Fe3O4 Janus particles for
the prospectivly use as carriers for target proteins and therapeutic
agents.
A special focus of our study lay on the direct comparison of
asymmetric Janus particles to normally used spherical iron oxide
nanoparticles. The comparison of different test systems showed
rather a proliferative effect (ATP assay) for the spherical ones.
Simultaneously, cellular ROS levels increased after incubation with
Fe3O4. The fact that the production of ROS initiates a non-linear
response with an initial increase in proliferation followed by a
decrease of viability is a well described phenomenon which is
known as hormesis [41,42]. Additionally, the Au@Fe3O4 Janus par-
ticles reduced the ROS level compared to non-treated control cells,
indicating that the gold domain of the Janus particles couldmediate
a protective activity against cytotoxic effects of their metal oxide
counterpart [43,44]. Since ROS production is associated with
inﬂammation, the application of Janus particles with intrinsic anti-
oxidative effects could represent a distinct advantage for their use
as contrast agent in patients carrying this disease. Furthermore,
studies with different cell lines of the blood system including pri-
mary cell lines substantiated the general harmlessness of Janus
particles. Therefore, we suggest that Janus nanoparticles in generalare less cytotoxic than spherical ones. Au@Fe3O4 Janus particles can
be used for biomedical applications under the same safety aspects
as clinically relevant spherical iron oxide nanoparticles; however,
they simultaneously offer the possibility for various imaging ap-
proaches and multiple ligand coupling.
The Janus particles with manganese oxide as metal component
revealed a stronger concentration-dependent reduction of the
cellular ATP levels compared to those with an iron oxide domain.
These observations were independent of nanoparticle uptake,
which was conﬁrmed by microscopic imaging and as well as semi-
quantitative analysis. Spherical Fe3O4 nanoparticles showed less
cytotoxic effects than MnO nanoparticles in rat liver cells [45], i.e.
there appears to be a compositional effect, which applies for the
spherical but also for asymmetric Janus particles. This means that
the gold domain of Janus particles is not able to “neutralize” the
MnO speciﬁc cytotoxic effects. As a result, Au@Fe3O4 Janus particles
would be the formulation of choice in prospective biomedical
applications.
Stronger effects of the MnO nanoparticles were also shown in
the time-dependent studies. This distinct reduction in the ATP
content may be caused by lethal cytotoxic effects (particularly for
increasing concentrations), which are known to occur as a result of
ROS production and the reduction in mitochondrial activity in a
dose-dependent manner [10]. Therefore, the process of nano-
particle internalization into the endothelial cells between 3 and
24 h of incubation is thought to be the deciding factor determining
their impact on cellular ATP metabolism.
Fig. 7. The structure of the endothelial surface inﬂuences Janus particle uptake. HMEC-1 were treated either with 1 mg/mL Fe(II)/(III) of the Au@Fe3O4 Janus particle variants or with
1 mg/mL Mn(II) of the Au-NH2@MnO Janus particles for 3 h at 37 C. (a) Bright-ﬁeld microscopy pictures of cells in the apical and basal orientation after incubation with the three
different Au@Fe3O4 Janus particle formulations. Red arrows depict nanoparticles (blue). Scale bars: 20 mm. Confocal ﬂuorescence and bright-ﬁeld (overlay) images of Au-NH2@MnO
internalization (b) after inversion of cells, (c) after trypsination and (d) after co-incubation with lectin WGA. White arrows depict nanoparticles (green). Nucleus: blue. The z-stack
shows the position of nanoparticles after inversion culture at the basal cell surface (for details see text).
L. Landgraf et al. / Biomaterials 35 (2014) 6986e6997 6995Considering the differences in the protein expression of the
apical and basal cell surface [31], the differential role of the
glycoprotein constitution in particle adsorption and internaliza-
tion might be responsible for the increased attraction of Janus
particles to the basal cell membrane. Particularly integrins, lami-
nin, collagen, and heparan sulphate proteoglycan are present at
the basal cell surface, which all are proteins responsible for (cell)
adhesion [46]. An increase in permeability, resulting from a
reduction of the thickness of the glycocalyx [47e49], was not
detectable. The observed WGA powered internalization is caused
by the binding of WGA to N-acetyl-D-glucosamine and sialic acid,
which in turn promotes cytoadhesion and cytoinvasion [50].
Furthermore, the binding of WGA prior to nanoparticle incubation
might induce an increased opening of a receptor-mediated
pathway [50]. The encountered effects could be exploited to fos-
ter the internalization of Janus particles into target cells in future
biomedical applications. In summary, the results illustrate the
importance of the membrane protein constitution during the
attachment of Janus particles. To gain a deeper understanding ofTable 1
Characteristics of Au@Fe3O4 Janus particles after suspension in water or complete Gibco
drodynamic diameter and Zeta-potentials were estimated in water and in complete cult
Core size Hydrodynamic diameter [nm]
Au@Fe3O4 In water PDI water
Au@Fe3O4 3.5 0.4@15.1 2.4 61 0.6 0.2 0.014
Au@Fe3O4-NH2 3.5 0.4@18.1 2.5 45 0.7 0.193 0.021
Au-NH2@Fe3O4 3.5 0.4@17.3 2.5 1060 608 0.782 0.324the processes, further investigations on the composition of the
basal cell membrane will be conducted.
Taken together, our Janus particles revealed a prospective use-
fulness for future in vivo investigations assessing their applicability
in future medicine. They have similar effects on cell viability and
uptake mechanisms as comparable spherical nanoparticles which
already played an important role in biomedicine in the last years.
Notably, Janus particles offer the capability for simultaneous
coupling of various ligands such as antibodies, peptides and drugs
without steric hindrance. Au@Fe3O4 Janus particles can prospec-
tively be used as target-afﬁne contrast agents. Furthermore, a
combinatorial therapy effect due to coupling of different chemo-
therapeutic agents is feasible.
5. Conclusions
We successfully performed multifactorial in vitro investigations
to get a deep insight into effects of newly developed Janus particles
which would be promising tools for future medical applications. MCDB 131 culture medium with 10% FBS. Core sizes were measured via TEM. Hy-
ure medium.
Zeta-potential [mV]
Culture medium PDI medium Water Culture medium
103 28 0.251 0.04 35 1.8 0.003 0.3
124 49.09 1.0 0.0 21 0.5 18 0.3
2527 1698 0.318 0.209 24 0.8 26 0.5
L. Landgraf et al. / Biomaterials 35 (2014) 6986e69976996We showed that HMEC-1 cells were sensitive to the surface
NH2-functionalization without a directed impact of the position of
the NH2-groups. Obviously, aggregation of the Au-NH2@Fe3O4 Ja-
nus particles which probably leads to sedimentation of this variant
have the highest impact on the cell viability attributed to an
increased nanoparticle concentration in close proximity to the cells.
Importantly, the bare Janus particles showed a distinct harmless-
ness to endothelial cells and even an anti-oxidative effect compared
to spherical iron oxide.
We show that Au@Fe3O4 Janus particles are compatible to four
different cell lines of the blood system. They display a compara-
tively low impact on cell metabolism of HMEC-1 compared to their
spherical counterparts. This applies also for their internalization
mechanisms into cells.
Au@Fe3O4 Janus nanoparticles combine the beneﬁts of spherical
gold and iron oxide nanoparticles and can be utilized for multi-
modal imaging and theranostic purposes. In addition, the potential
use of Janus particles in future medical applications is endorsed
because they can be considered patient-friendly because multiple
diagnostic and therapeutic clinical outcomes can be obtained after
a single Janus particle administration.Acknowledgement
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